Xylome is an industrial biotechnology solutions company
Xylome’s genetic tools, metabolic engineering and adaptive techniques can modify a range of unconventional yeast platforms for new metabolic pathways and the biosynthesis of advanced products such as Palm Oil Substitutes, Enzymes and Fish Meal Substitutes.
Unconventional yeasts have metabolic capabilities that go well beyond Saccharomyces in substrate utilization and product formation profiles. Our proprietary strains and genetic toolbox can enable more efficient formation of established products and open doors to novel biosyntheses.
Xylome’s proprietary strain of a native, non-GMO yeast that efficiently co-ferments glucose, xylose and cellobiose from a wide range of cellulosic hydrolysates and other organic waste streams
Xylome’s native xylose and cellobiose ethanologen:
SPCX-01 is ideal for add-on fermentations that can generate 60-70 g/L of ethanol from pentose sugars from ethanol plant by-products
Xylome’s process to generate a palm oil substitute and starch degrading enzymes from ethanol plant by-products
Xylome’s process to generate an omega-3 fish meal for aquaculture and animal feed purposes from ethanol plant by-products
Xylome is seeking strategic partners and/ or equity investors:
- Ideally, first adopter for demonstration projects
- Marketing/ commercialization leads for our technologies
Inquire about Xylome’s wide range of non-conventional yeasts and molecular technologies that can be specifically tailored to your needs.
- Research licenses available
- Non-Disclosure and Material Transfer agreements required
- Commercial licenses based on product sales, royalties and sub-licensing agreements